Recent presentations
Calviri is positioned to become an integral part of cancer care
CalviriRNA Frameshift Errors Provide New Vaccine Product Opportunities against Cancer
World Vaccine CongressEnd deaths from Cancer – Calviri presents investment opportunitiy during JP Morgan, 2020…
JP Morgan
Previous presentations
Below is a list of conferences and events Calviri has previously presented at.
2019
Going to the Dogs – How the Largest Canine Clinical Trial in History May Lead to New Hope for Humans
Arizona Bioindustry Association
Shifting the paradigm in diagnosing and treating cancer
Midwestern University
RNA generated frameshift neoantigens in tumors are useful in diagnosis and vaccination
Molecular Med Tri-Con
Using a blood-based 400K frameshift peptide array to develop cancer type-specific vaccinations
Molecular Med Tri-Con
A new source of neoantigens and a platform for their discovery
PepTalk
2018
Cancer type specific FAST vaccines based on frameshift neoantigens
Molecular Med Tri-Con
Tapping a new source of neoantigens: applications in therapy and diagnostics
Immune Oncology Summit
A new blood based approach to early diagnosis of cancer
American College of Veterinary Internal Medicine
Calviri’s Technology Enables a Universal Preventative Vaccine
Golden Retriever Club of America
Inventions to effectively eradicate cancer
United States Patent and Trademark Office
Shifting the paradigm in diagnosing and treating cancer
European NeoAG Summit
2017
An alternative source of neoantigens offers new approaches to personal and general vaccines
Golden Retriever Club of America